We aimed to assess whether GCKR rs780094 C→T SNP influences the expression of steatosis, lobular inflammation and fibrosis in NAFLD patients, after correction for PNPLA3 genotype. The gene discussed is GCKR; the disease is metabolic dysfunction-associated steatotic liver disease.